National Human Genome Research Institute; Notice of Closed Meetings, 63566-63567 [2015-26559]
Download as PDF
<![CDATA[
63566
Federal Register / Vol. 80, No. 202 / Tuesday, October 20, 2015 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of MIRA Applications.
Date: November 9–10, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Brian R. Pike, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3An.12P, Bethesda, MD
20892, 301–594–2048, pikbr@mail.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of MIRA Applications.
Date: November 9–10, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Lisa A. Dunbar, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3An.12C, Bethesda, MD
20892, 301–594–2048, dunbarl@mail.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of MIRA Applications.
Date: November 9–10, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
North Bethesda, MD 20852,
Contact Person: Saraswathy Seetharam
Ph.D., Scientific Review Officer, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3An.12C,
Bethesda, MD 20892, 301–594–2048,
seetharams@nigms.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of MIRA Applications.
Date: November 9–10, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Robert Horowits, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3An.12H, Bethesda, MD
20892, 301–594–2048, horowitr@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
VerDate Sep<11>2014
17:55 Oct 19, 2015
Jkt 238001
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: October 14, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–26550 Filed 10–19–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Drug
Discovery for the Nervous System.
Date: November 10, 2015.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Geoffrey G. Schofield,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040–A,
MSC 7850, Bethesda, MD 20892, 301–435–
1235, geoffreys@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Immunology.
Date: November 12, 2015.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Jin Huang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4095G,
MSC 7812, Bethesda, MD 20892, 301–435–
1230, jh377p@nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group; AIDS
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
Molecular and Cellular Biology Study
Section.
Date: November 16, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Washington DC,
Dupont Circle, 1143 New Hampshire Avenue
NW., Washington, DC 20037.
Contact Person: Kenneth A. Roebuck,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214,
MSC 7852, Bethesda, MD 20892, (301) 435–
1166, roebuckk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Cancer Drug Development and
Therapeutics.
Date: November 16–17, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Nikko San Francisco, 222
Mason Street, San Francisco, CA 94102.
Contact Person: Lilia Topol, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892, 301–451–
0131, ltopol@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Cardiovascular and Surgical
Devices.
Date: November 16, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Crystal City, 2399 Jefferson
Davis Hwy., Arlington, VA 22202.
Contact Person: Jan Li, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5106,
Bethesda, MD 20892, 301.435.1049, lij21@
csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 14, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–26502 Filed 10–19–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
E:\FR\FM\20OCN1.SGM
20OCN1
Federal Register / Vol. 80, No. 202 / Tuesday, October 20, 2015 / Notices
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Diversity Action Plan (DAP).
Date: November 9, 2015.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, 3rd Floor Conference Room, 5635
Fishers Lane, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer, NHGRI, 5635
Fishers Lane, Suite 4076, Bethesda, MD
20814, 301–594–4280.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; High Quality Genome Sequences.
Date: November 19, 2015.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, 3rd Floor Conference Room, 5635
Fishers Lane, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Lita Proctor, Ph.D.,
Extramural Research Programs Staff, Program
Director, Human Microbiome Project,
National Human Genome Research Institute,
5635 Fishers Lane, Suite 4076, Bethesda, MD
20892, 301 496–4550, proctorlm@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: October 14, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–26559 Filed 10–19–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK4VPTVN1PROD with NOTICES
National Institutes of Health
Announcement of Requirements and
Registration for the Open Science
Prize
Authority: 15 U.S.C. 3719
Award Approving Official: Philip E.
Bourne, Associate Director, NIH OD.
SUMMARY: The National Institutes of
Health (NIH) Office of the Associate
VerDate Sep<11>2014
17:55 Oct 19, 2015
Jkt 238001
Director for Data Science (ADDS)
announces a collaboration with the
Wellcome Trust (WT) and the Howard
Hughes Medical Institute (HHMI) to
launch the ‘‘Open Science Prize’’ (the
‘‘Challenge’’) to encourage and support
the prototyping and development of
services, tools and/or platforms that
enable open content—including
publications, datasets, code and other
research outputs—to be discovered,
accessed and re-used in ways that will
advance research, spark innovation, and
generate new societal benefits. The
Challenge is necessary to accelerate the
field of ‘‘open’’ biomedical research
beyond what current funding
mechanisms can achieve. For the NIH,
this Challenge is being launched under
the America COMPETES
Reauthorization Act of 2010.
DATES:
February 29, 2016: Phase I
submissions due
April 30, 2016: Announce Phase I
winners; Phase II begins
December 1, 2016: Phase II
submissions due
February 28, 2017: Phase II winner
announced
The NIH will announce any changes
to the timeline by amending this
Federal Register notice.
ADDRESSES: To register for this
Challenge, Challenge participants may
access the registration on the Challenge
Web site (www.openscienceprize.org).
Access to this Web site may also be
found by searching the
www.challenge.gov site for the ‘‘Open
Science Prize.’’
FOR FURTHER INFORMATION CONTACT:
Audie A. Atienza, Ph.D. (NIH),
Audie.Atienza@nih.gov; Vinay Pai,
Ph.D. (NIH), paiv@mail.nih.gov; David
Carr (Wellcome Trust), d.carr@
wellcome.ac.uk.
SUPPLEMENTARY INFORMATION:
Subject of Challenge
In order to stimulate innovation, the
National Institutes of Health (NIH)
Office of the Associate Director for Data
Science (ADDS), in conjunction with
Challenge Partners, the Wellcome Trust
(WT) and the Howard Hughes Medical
Institute (HHMI), is launching the
‘‘Open Science Prize’’ (the ‘‘Challenge’’);
a prize competition to inspire the
prototyping and development of
services, tools, or platforms that enable
open content—including publications,
datasets, code and other research
outputs—to be discovered, accessed and
re-used in ways that will advance
research, spark innovation and generate
new societal benefits. The NIH is using
the America Creating Opportunities to
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
63567
Meaningfully Promote Excellence in
Technology, Education, and Science
(COMPETES) Reauthorization Act of
2010 to support this Challenge.
The goal of this Challenge is to
stimulate the development of novel and
ground-breaking tools and platforms to
enable the reuse and repurposing of
open digital research objects (e.g. data,
publications, other research outputs)
relevant to biomedical or health
applications. The volume of digital
objects for research available to
researchers and the wider public is
greater now than ever before, and so,
consequently, are the opportunities to
mine and extract value from existing
open content and to generate new
discoveries and other societal benefits.
A key obstacle in realizing these
benefits is the discoverability of open
content, and the ability to access and
utilize it.
This Challenge provides a new and
innovative avenue for developing the
best ideas in this arena. Through the
Challenge, the NIH, WT, and HHMI
hope to encourage novel ideas and
innovations that seek to unlock the vast
potential benefits of making biomedical/
health content and data open and reuseable, to demonstrate the huge
potential value of open science
approaches, and to generate excitement,
momentum, and further investment.
This Challenge also encourages
international collaborations among
technology innovators, health
researchers, and biomedical informatics
entities to address ‘‘Open Science’’
development. In building partnerships
between innovators in the U.S. and
abroad, unique resources can be
combined and leveraged to facilitate
global health research objectives
relevant to the mission of the NIH,
increase rapid adoption of Open Science
research tools across the globe, and
enhance the generalizability of data
sharing among researchers and
practitioners internationally.
The NIH, WT, and HHMI are seeking
to utilize the developer challenge model
in the area of ‘‘Open Science’’ that is as
open, flexible, and interactive as
possible, so as to encourage the
development of new collaborations as
well as new ideas. Solvers are invited to
use innovative approaches to develop
applications and platforms that
integrate, repurpose and/or repackage
open digital resources relevant to health
and biomedical research. The Challenge
is open both to those who have new
ideas and require some funding to take
it to the prototype stage, and those with
initial early-stage prototypes who wish
to develop them further for crossnational or international adoption.
E:\FR\FM\20OCN1.SGM
20OCN1
]]>Agencies
[Federal Register Volume 80, Number 202 (Tuesday, October 20, 2015)]
[Notices]
[Pages 63566-63567]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-26559]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
[[Page 63567]]
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Human Genome Research Institute
Special Emphasis Panel; Diversity Action Plan (DAP).
Date: November 9, 2015.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Human Genome Research Institute, 3rd Floor
Conference Room, 5635 Fishers Lane, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Keith McKenney, Ph.D., Scientific Review
Officer, NHGRI, 5635 Fishers Lane, Suite 4076, Bethesda, MD 20814,
301-594-4280.
Name of Committee: National Human Genome Research Institute
Special Emphasis Panel; High Quality Genome Sequences.
Date: November 19, 2015.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Human Genome Research Institute, 3rd Floor
Conference Room, 5635 Fishers Lane, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Lita Proctor, Ph.D., Extramural Research
Programs Staff, Program Director, Human Microbiome Project, National
Human Genome Research Institute, 5635 Fishers Lane, Suite 4076,
Bethesda, MD 20892, 301 496-4550, proctorlm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS)
Dated: October 14, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-26559 Filed 10-19-15; 8:45 am]
BILLING CODE 4140-01-P
